| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/04/2010 | US20100055033 Antibody compositions and methods for treatment of neoplastic disease |
| 03/04/2010 | US20100050501 Intergeneric hybrid plants and methods for production thereof |
| 03/04/2010 | DE102008039734A1 Stabilisierung von Zellen durch ionische Flüssigkeiten Stabilization of cells by ionic liquids |
| 03/04/2010 | CA2741754A1 High-throughput and non-invasive method to vitrify porcine embryos |
| 03/04/2010 | CA2735605A1 Plant glutamine phenylpyruvate transaminase gene and transgenic plants carrying same |
| 03/04/2010 | CA2735583A1 Methods of identifying functional characteristics of promoters, transcription modifying proteins and transcription modulating agents |
| 03/04/2010 | CA2735412A1 Enhanced animal cell growth using ultrasound |
| 03/03/2010 | EP2159577A1 Novel marker for arteriosclerotic disease |
| 03/03/2010 | EP2159281A1 Novel slc17-type transporter protein in mammal and use thereof |
| 03/03/2010 | EP2159230A1 Anti-TNF antibodies, compositions, methods and uses |
| 03/03/2010 | EP2158319A1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 03/03/2010 | EP2158311A1 Stabilisation of the phenotypic properties of isolated primary cells |
| 03/03/2010 | EP2158310A1 Optical method and device for detection and enumeration of microorganisms |
| 03/03/2010 | EP2158216A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 03/03/2010 | EP2158211A2 Mutated structural protein of a parvovirus |
| 03/03/2010 | EP1966367B1 Bioreactor for cell and tissue culture |
| 03/03/2010 | EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative |
| 03/03/2010 | EP1694848B1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 03/03/2010 | EP1490482B1 Host cells having improved cell survival properties and methods to generate such cells |
| 03/03/2010 | EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury |
| 03/03/2010 | EP0990030B1 Transcriptional activators with graded transactivation potential |
| 03/03/2010 | EP0859831B1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 03/03/2010 | CN101663392A Cancerous disease modifying antibodies |
| 03/03/2010 | CN101663391A Cell culture method using amino acid-enriched medium |
| 03/03/2010 | CN101663390A Cell culture improvements |
| 03/03/2010 | CN101659941A Immortalized human liver cell line, preparation method and application thereof |
| 03/02/2010 | US7671257 Inbred corn line G07-NPDI4214 |
| 03/02/2010 | US7671254 Herbicide resistance gene, compositions and methods |
| 03/02/2010 | US7671253 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
| 03/02/2010 | US7671252 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 03/02/2010 | US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes |
| 03/02/2010 | US7671189 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671035 Epidermal growth factor receptor antisense oligonucleotides |
| 03/02/2010 | US7671016 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 03/02/2010 | US7670839 Process for coating cell-culture support |
| 03/02/2010 | US7670838 Calcium channel modulators; inhibiting neurogenesis; N-methyl-D-asparate (NMDA) receptors |
| 03/02/2010 | US7670837 Non-tumorigenic MDCK cell line for propagating viruses |
| 03/02/2010 | US7670823 Compositions for use in recombinational cloning of nucleic acids |
| 03/02/2010 | US7670818 β-mannanase from coffee berry borer, hypothenemus hampei, and uses thereof |
| 03/02/2010 | US7670816 UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1 |
| 03/02/2010 | US7670801 Using immunoglobulins to isolate heterologous polypeptide fusion comprising viral coat sequences in adenoviral protein expression systems of plants, animals and bacteria |
| 03/02/2010 | US7670797 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined |
| 03/02/2010 | US7670781 Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal |
| 03/02/2010 | US7670771 Assessing human predisposition to a febrile seizure disorder |
| 03/02/2010 | US7670763 determining sperm quality, and different storage media's effect thereon; male fertility |
| 03/02/2010 | US7670632 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 03/02/2010 | US7670628 Mesenchymal precursor cell |
| 03/02/2010 | US7670611 Cancer immunotherapy with semi-allogeneic cells |
| 03/02/2010 | US7670602 Concatameric immunoadhesion molecule |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | US7670596 Multi-lineage progenitor cells |
| 03/02/2010 | CA2390659C Ny-eso-1 peptide derivatives, and uses thereof |
| 02/25/2010 | WO2010022395A2 Methods of reprogramming cells |
| 02/25/2010 | WO2010022194A2 Compositions and methods for generation of pluripotent stem cells |
| 02/25/2010 | WO2010021993A1 Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| 02/25/2010 | WO2010021756A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/25/2010 | WO2010021715A1 Treatment of stroke using isolated placental cells |
| 02/25/2010 | WO2010021714A2 Improved cell composition and methods of making the same |
| 02/25/2010 | WO2010021697A2 Antibodies to ccr2 |
| 02/25/2010 | WO2010021392A1 In vitro fluorescence observation method for mammal embryo, and method for selecting mammal embryo reduced in risk of implantation failure or abortion |
| 02/25/2010 | WO2010021390A1 ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION |
| 02/25/2010 | WO2010021245A1 Method for culture of hair dermal papilla cell |
| 02/25/2010 | WO2010020876A2 Cell culture method |
| 02/25/2010 | WO2010020618A1 Susceptibility to hsp90-inhibitors |
| 02/25/2010 | WO2010020005A1 Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes |
| 02/25/2010 | WO2010019997A1 Monoclonal antibody stro-4 |
| 02/25/2010 | WO2009147209A3 Method for and material of a shape standard |
| 02/25/2010 | WO2009140260A3 Cancer stem cell immortalization |
| 02/25/2010 | WO2009137632A3 Hiv immunogen and method of making and using same |
| 02/25/2010 | WO2009135905A3 Mesenchymal stem cells and bone-forming cells |
| 02/25/2010 | WO2009135181A3 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 02/25/2010 | WO2009134866A3 Cell membrane engineering |
| 02/25/2010 | WO2009126927A3 Methods of generating insulin-producing cells |
| 02/25/2010 | WO2009124213A3 Dental stem cell differentiation |
| 02/25/2010 | WO2009114702A3 Recombinant production of authentic human proteins using human cell expression systems |
| 02/25/2010 | WO2009072142A4 Jathropha curcas hybrid nandan-2 for high oil content and construction of molecular markers specific to it |
| 02/25/2010 | WO2008120218A3 Undifferentiated stem cell culture systems |
| 02/25/2010 | WO2008099385A3 Methods and kits for qualifying sperm cells |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100050304 Brown midrib sudangrass hybrids with improved forage quality |
| 02/25/2010 | US20100050303 Antimicrobial Agents from Microbial Genomes |
| 02/25/2010 | US20100050298 Mutants of pha synthase from pseudomonas sp. 6-19 and method for preparing lactate homopolymer or copolymer using the same |
| 02/25/2010 | US20100050296 Preparation of organisms with faster growth and/or higher yield |
| 02/25/2010 | US20100050294 Method for modifying insect resistance of plants by utilizing rnai technique |
| 02/25/2010 | US20100050293 Improvement of nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 02/25/2010 | US20100050289 energy-absorbing coverings for use in conjunction with a laser-induced shock process; comprising energy-absorbing particulate graphite, carbon black, and black iron oxide (Fe3O4) dispersed within the liquid hydrocarbon petroleum oil, vegetable oil, mineral oil; providing shockwaves |
| 02/25/2010 | US20100050286 Soybean variety d5897564 |
| 02/25/2010 | US20100050282 Herbicide Tolerant Cotton Plants and Methods for Identifying the Same |
| 02/25/2010 | US20100050279 High efficiency flp site-specific recombination in mammalian cells using an optimized flp gene |
| 02/25/2010 | US20100050278 Application of Actin-Binding Protein to Disease Associated With Cell Motility |
| 02/25/2010 | US20100049273 Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders |
| 02/25/2010 | US20100048727 Perfluoroketone compounds and uses thereof |
| 02/25/2010 | US20100048714 Methods and Compositions Related to Inhibition of Ceramide Synthesis |
| 02/25/2010 | US20100048684 EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRES METALLOPROTEINASE CLEAVAGE OF proHB-EGF |
| 02/25/2010 | US20100048682 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 02/25/2010 | US20100048680 Alpha-1-Antitrypsin Variants and Uses Thereof |
| 02/25/2010 | US20100048675 miRNA TRIPLEX FORMATIONS FOR THE DOWNREGULATION OF VIRAL REPLICATION |